enVVeno Medical Corp: SATTERFIELD THOMAS A JR amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Satterfield Thomas A Jr amended his Schedule 13G beneficial ownership filing for enVVeno Medical Corp, disclosing the change to the SEC under accession number 0001104659-26-125054. The filing updates his previously reported passive stake in the medical device maker, though the amended document did not specify a revised share count or percentage in the headline details. Schedule 13G amendments are typically watched for signals about whether large holders are accumulating or trimming positions. Investors will look to the full filing for the exact share total and any change in ownership percentage.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
SATTERFIELD THOMAS A JR, enVVeno Medical Corp